COMMENTARY - Doctors Illegally Enrich Themselves: Health Insurers Must Now Be Held Accountable

Doctors are illegally pocketing hundreds of millions of Swiss francs each year through a murky rebate system, according to a commentary in the Neue Zürcher Zeitung. This practice diverts funds that should benefit policyholders back to medical professionals.

The scandal lies not in the drug manufacturers offering lower prices, which indicates healthy competition. Instead, the issue is that the savings from these discounts rarely reach the public. While the law mandates that at least 51% of these rebates should go to health insurance companies, the reality is starkly different. The Swiss Federal Audit Office (EFK) estimates that only about 88 million Swiss francs, out of a potential 370 million, are returned to premium payers.

A significant number of practice owners and pharmacies are suspected of illegally enriching themselves with tens of millions of francs. While hospitals, often facing financial difficulties, might be seen more leniently, the practice is particularly criticized when it involves specialist doctors who already earn high incomes. This raises concerns that some physicians may prioritize their own financial gain over patient well-being, prescribing drugs based on profitability rather than medical necessity.

Even rebates that are legally compliant face scrutiny. Doctors are permitted to keep up to 49% of these rebates, but they are officially required to invest this money in improving medical quality, following specific guidelines. However, industry insiders suspect this is often a facade. The commentary questions why such quality-improving measures are not made mandatory for all practices if they are truly essential, suggesting the current system may be circumvented.